Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Observational Study to Describe Health-Related Quality of Life and Disease Burden Among Patients With Long QT Syndrome (LQTS) 2 and 3

NCT07075445 is registered in ClinicalTrials.gov with Thryv Therapeutics, Inc. as lead sponsor.

NCT NCT07075445
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07075445 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Observational Study to Describe Health-Related Quality of Life and Disease Burden Among Patients With Long QT Syndrome (LQTS) 2 and 3
Lead sponsor
Thryv Therapeutics, Inc.
Phase
Observational
Overall status
Active, not recruiting
Start date
October 27, 2025
Completion date
December 1, 2026
Enrollment
200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

long qt syndrome 2, long qt syndrome type 3